The global multi-omics solution
for precision oncology
Indivumed GmbH was founded in 2002 by leading scientists with a drive to revolutionize cancer treatment through individualized therapy.
As a physician-led, integrated global oncology company our experts leverage the world’s premier multi-omics oncology database and highest quality biobank to develop a true picture of cancer.
Our three divisions operate holistically with one another for the generation, characterization, and analysis of biologic samples from human cancer patients.
Indivumed is headquartered in Hamburg, Germany, with a US-based subsidiary and a global clinical network.
Company History
Since its founding, Indivumed has grown exponentially, our reputation for product and service quality and relationships expanding across the globe. We are always looking to the horizon for new partnerships and methods to support the realization of our vision.
Explore the highlights of our journey:
Indivumed Management
“At Indivumed we are united by a shared responsibility: using our unique expertise and skill sets to work toward individualized cancer diagnosis and treatment for every patient.”
Prof. Dr. Hartmut Juhl, Indivumed CEO
Hartmut holds a professorship at the Medical Faculty of Hamburg University, is an adjunct professor at the Lombardi Cancer Center of Georgetown University, and has served as an advisor to the U.S. National Cancer Institute on matters of tissue quality for clinical and research applications.
From 1987 to 1992, he worked as a research associate and resident at the Hamburg-Eppendorf Surgical University Clinic. In 1992 he moved to the Surgical Clinic of the Christians Albrecht University in Kiel, where he worked as a surgical oncologist and, simultaneously, led a molecular oncology research group until 1998. He became a specialist in general surgery (“Facharzt”) in 1995. In 1999, he became Associate Professor at the Lombardi Cancer Center of Georgetown University.
In 2002, Hartmut became co-founder of Indivumed GmbH in Hamburg and was awarded the “Hamburg Foundation Prize” in the category of “Founders of new Businesses” in 2003, as well as the German Foundation Prize in the category of “New Visionary” in 2005.
In 2004, he founded Indivumed Inc, a subsidiary of Indivumed GmbH, to cover the US business. In 2008, Hartmut initiated the foundation of Inostics GmbH, a subsidiary of Indivumed GmbH, jointly owned with scientists from Johns Hopkins University, Baltimore, Maryland.
In 2011 Hartmut founded IndivuTest, a specialized diagnostic lab to individualize cancer therapy, as a subsidiary of Indivumed. He successfully closed six rounds of financing to build up and grow Indivumed GmbH and its subsidiaries, respectively, and in 2013, he successfully managed the sale of Inostics GmbH to Sysmex Corporation.
Hartmut studied medicine at the Hamburg-Eppendorf University Clinic from 1979 to 1986. He received his doctorate of medicine (Dr. med.) in 1989, and his “Habilitation” in Surgical Oncology in 1996.
Contact: Juhl@indivumed.com
Fernando Andreu has been working in the Medical Devices and In Vitro Diagnostics fields for more than 25 years and brings to the table his considerable amount of knowledge and experience. His focus lies on using technology to improve healthcare processes and patient outcomes. Throughout his career, he has led from management positions the development and commercialization of several innovations such as, among others, a platform to remotely connect people with diabetes and their doctors, the decentralization of therapies with anticoagulant drugs, a breast cancer database for translational research purposes and the first liquid biopsy IVD test for colorectal cancer.
Before joining Indivumed in 2018, Fernando was a Senior Executive Officer at Sysmex Europe and CEO at Sysmex Inostics, the liquid biopsy affiliate of Sysmex. He has also held management responsibilities at companies like Roche Diagnostics and Chiron Diagnostics (formerly Ciba Corning).
In parallel to his professional development, he has been part of the Strategy Department at ESADE Business School in Barcelona, teaching courses on Business Strategy and Entrepreneurship for more than ten years.
Contact: Andreu@indivumed.com
Dr. Susanne Arbogast brings to Indivumed more than ten years of experience in implementing research and development programs with a strong focus on (immuno-) oncology projects. This is paired with her extensive expertise in global management of the interface between pharma and diagnostics, as well as a broad external scientific network.
Susanne is a full board certified anatomical and surgical pathologist. She studied medicine at the University of Freiburg, Harvard Medical School, and the LMU Munich, receiving her doctorate of medicine (Dr. med.) in 1992.
She worked at the Pathology Institute of the LMU Munich for more than 15 years, most recently as assistant medical director. In 2007, Susanne joined Roche as Global Head of Pathology and Tissue Biomarkers, responsible for setting up and running a global team (Europe/US/China) to drive all tissue-related discovery and clinical biomarker programs to enable personalized health care.
Contact: Arbogast@indivumed.com
Nils Schumacher brings over 20 years of in-house legal experience to Indivumed, with a particular emphasis on contract, corporate and IP law.
Nils’ diverse work experience includes having served as a legal advisor, HR director and corporate secretary. Prior to joining Indivumed in 2017, Nils worked at a venture capital and private equity-financed multinational start-up, for an internationally operating developer and distributor of software solutions and IT media, for an IT business consultancy and for a US law firm.
As a qualified lawyer (diploma from Friedrich-Alexander-University Erlangen and Bavarian state examinations) and an admitted solicitor, Nils holds a master’s degree in business mediation from IUKB Sion, as well as a diploma in business administration from Hagen University.
Contact: Schumacher@indivumed.com
The Indivumed Clinical Network
Indivumed has established close and long-standing partnerships with leading hospitals, clinics, and biopharma institutes in Europe, North America, and Asia.
The collaboration with these institutions is the basis for maintaining and expanding Indivumed’s high-quality biospecimens, clinical data, and breakthrough research techniques. Indivumed is continually expanding its clinical network in order to provide even better products and services for oncological drug discovery and development programs.
Career Opportunities
Indivumed has approximately 200 employees in Germany, Poland, the USA, and India. We are a future-oriented company with an ambitious growth strategy, proud of our innovative team of leading scientists, and of our international reputation. At Indivumed you have the chance to pursue your professional goals and benefit from quick decision processes – thanks to flat hierarchies and ample creative freedom.
Looking for a secure job with exciting challenges?
Then apply for one of the following vacancies. Simply e-mail us your completed application documents to jobs@indivumed.com. Please indicate the job title in the subject line. Of course, all information you provide will be treated in the strictest confidence.
Current Job vacancies
If you would like to learn more about working at Indivumed, please contact our human resources department at:
Indivumed GmbH
Human Resources
Falkenried 88, Bldg. D
20251 Hamburg
Germany
Phone: +49-40-413-3830
E-mail: jobs@indivumed.com
